omega-agatoxin IVA-sensitive Ca(2+) channel blocker, alpha-eudesmol, protects against brain injury after focal ischemia in rats

omega-Agatoxin IVA-sensitive Ca(2+) channels have been thought to be involved in physiological excitatory amino acid glutamate release and these channels may also contribute to the development of ischemic brain injury. Recently, we demonstrated that alpha-eudesmol from Juniperus virginiana Linn. (Cu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 2000-04, Vol.394 (1), p.57
Hauptverfasser: Asakura, K, Matsuo, Y, Oshima, T, Kihara, T, Minagawa, K, Araki, Y, Kagawa, K, Kanemasa, T, Ninomiya, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 57
container_title European journal of pharmacology
container_volume 394
creator Asakura, K
Matsuo, Y
Oshima, T
Kihara, T
Minagawa, K
Araki, Y
Kagawa, K
Kanemasa, T
Ninomiya, M
description omega-Agatoxin IVA-sensitive Ca(2+) channels have been thought to be involved in physiological excitatory amino acid glutamate release and these channels may also contribute to the development of ischemic brain injury. Recently, we demonstrated that alpha-eudesmol from Juniperus virginiana Linn. (Cupressaceae) inhibits potently the presynaptic omega-agatoxin IVA-sensitive Ca(2+) channels. In the present study, we investigated the effects of alpha-eudesmol on brain edema formation and infarct size determined after 24 h of reperfusion following 1 h of middle cerebral artery occlusion in rats. We first found that alpha-eudesmol concentration-dependently inhibited glutamate release from rat brain synaptosomes and that its inhibitory effect was Ca(2+)-dependent. In the middle cerebral artery occlusion study, intracerebroventricular (i.c.v.) treatment with alpha-eudesmol significantly attenuated the post-ischemic increase in brain water content. alpha-Eudesmol also significantly reduced the size of the infarct area determined by triphenyltetrazolium chloride staining after 24 h of reperfusion. Using a microdialysis technique, we further demonstrated that alpha-eudesmol inhibits the elevation of the extracellular concentration of glutamate during ischemia. From these results, we suggest that alpha-eudesmol displays an ability to inhibit exocytotic glutamate release and to attenuate post-ischemic brain injury.
doi_str_mv 10.1016/S0014-2999(00)00102-3
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_10771035</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10771035</sourcerecordid><originalsourceid>FETCH-LOGICAL-p122t-b8f6fd62c01d6b9e6bd689fa8916625aa8182cbb0dd68518e7713bd2bbdd90ae3</originalsourceid><addsrcrecordid>eNo9kMtLAzEYxHNQbK3-CUqOLTb6Jeumm2MpPgoFDz6u5ctj29R9kaRiT_7rLvg4_ZgZGJgh5ILDNQcub54B-C0TSqkxwKQXIFh2RIb_9oCcxrgDgFyJ_IQMOMxmHLJ8SL7a2m2Q4QZT--kbunybs-ia6JP_cHSBY3E1oWaLTeMqqqvWvLswpVh1W2Rub12s22pKu9AmZ1KkfY9vYqI69KS-2e3DgWKZXKBla7CiPpqtqz32GQ2Y4hk5LrGK7vyXI_J6f_eyeGSrp4flYr5iHRciMV2UsrRSGOBWauWktrJQJRaKSylyxIIXwmgNtvdzXrh-X6at0NpaBeiyEbn86e32unZ23QVfYzis_57IvgHRqmEH</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>omega-agatoxin IVA-sensitive Ca(2+) channel blocker, alpha-eudesmol, protects against brain injury after focal ischemia in rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Asakura, K ; Matsuo, Y ; Oshima, T ; Kihara, T ; Minagawa, K ; Araki, Y ; Kagawa, K ; Kanemasa, T ; Ninomiya, M</creator><creatorcontrib>Asakura, K ; Matsuo, Y ; Oshima, T ; Kihara, T ; Minagawa, K ; Araki, Y ; Kagawa, K ; Kanemasa, T ; Ninomiya, M</creatorcontrib><description>omega-Agatoxin IVA-sensitive Ca(2+) channels have been thought to be involved in physiological excitatory amino acid glutamate release and these channels may also contribute to the development of ischemic brain injury. Recently, we demonstrated that alpha-eudesmol from Juniperus virginiana Linn. (Cupressaceae) inhibits potently the presynaptic omega-agatoxin IVA-sensitive Ca(2+) channels. In the present study, we investigated the effects of alpha-eudesmol on brain edema formation and infarct size determined after 24 h of reperfusion following 1 h of middle cerebral artery occlusion in rats. We first found that alpha-eudesmol concentration-dependently inhibited glutamate release from rat brain synaptosomes and that its inhibitory effect was Ca(2+)-dependent. In the middle cerebral artery occlusion study, intracerebroventricular (i.c.v.) treatment with alpha-eudesmol significantly attenuated the post-ischemic increase in brain water content. alpha-Eudesmol also significantly reduced the size of the infarct area determined by triphenyltetrazolium chloride staining after 24 h of reperfusion. Using a microdialysis technique, we further demonstrated that alpha-eudesmol inhibits the elevation of the extracellular concentration of glutamate during ischemia. From these results, we suggest that alpha-eudesmol displays an ability to inhibit exocytotic glutamate release and to attenuate post-ischemic brain injury.</description><identifier>ISSN: 0014-2999</identifier><identifier>DOI: 10.1016/S0014-2999(00)00102-3</identifier><identifier>PMID: 10771035</identifier><language>eng</language><publisher>Netherlands</publisher><subject>Animals ; Brain Edema - prevention &amp; control ; Brain Ischemia - drug therapy ; Calcium Channel Blockers - pharmacology ; Cerebral Infarction - prevention &amp; control ; Dose-Response Relationship, Drug ; Glutamic Acid - metabolism ; Male ; Neuroprotective Agents - pharmacology ; omega-Agatoxin IVA - pharmacology ; Potassium - pharmacology ; Rats ; Rats, Sprague-Dawley ; Rats, Wistar ; Sesquiterpenes, Eudesmane ; Terpenes - pharmacology</subject><ispartof>European journal of pharmacology, 2000-04, Vol.394 (1), p.57</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10771035$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Asakura, K</creatorcontrib><creatorcontrib>Matsuo, Y</creatorcontrib><creatorcontrib>Oshima, T</creatorcontrib><creatorcontrib>Kihara, T</creatorcontrib><creatorcontrib>Minagawa, K</creatorcontrib><creatorcontrib>Araki, Y</creatorcontrib><creatorcontrib>Kagawa, K</creatorcontrib><creatorcontrib>Kanemasa, T</creatorcontrib><creatorcontrib>Ninomiya, M</creatorcontrib><title>omega-agatoxin IVA-sensitive Ca(2+) channel blocker, alpha-eudesmol, protects against brain injury after focal ischemia in rats</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>omega-Agatoxin IVA-sensitive Ca(2+) channels have been thought to be involved in physiological excitatory amino acid glutamate release and these channels may also contribute to the development of ischemic brain injury. Recently, we demonstrated that alpha-eudesmol from Juniperus virginiana Linn. (Cupressaceae) inhibits potently the presynaptic omega-agatoxin IVA-sensitive Ca(2+) channels. In the present study, we investigated the effects of alpha-eudesmol on brain edema formation and infarct size determined after 24 h of reperfusion following 1 h of middle cerebral artery occlusion in rats. We first found that alpha-eudesmol concentration-dependently inhibited glutamate release from rat brain synaptosomes and that its inhibitory effect was Ca(2+)-dependent. In the middle cerebral artery occlusion study, intracerebroventricular (i.c.v.) treatment with alpha-eudesmol significantly attenuated the post-ischemic increase in brain water content. alpha-Eudesmol also significantly reduced the size of the infarct area determined by triphenyltetrazolium chloride staining after 24 h of reperfusion. Using a microdialysis technique, we further demonstrated that alpha-eudesmol inhibits the elevation of the extracellular concentration of glutamate during ischemia. From these results, we suggest that alpha-eudesmol displays an ability to inhibit exocytotic glutamate release and to attenuate post-ischemic brain injury.</description><subject>Animals</subject><subject>Brain Edema - prevention &amp; control</subject><subject>Brain Ischemia - drug therapy</subject><subject>Calcium Channel Blockers - pharmacology</subject><subject>Cerebral Infarction - prevention &amp; control</subject><subject>Dose-Response Relationship, Drug</subject><subject>Glutamic Acid - metabolism</subject><subject>Male</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>omega-Agatoxin IVA - pharmacology</subject><subject>Potassium - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Rats, Wistar</subject><subject>Sesquiterpenes, Eudesmane</subject><subject>Terpenes - pharmacology</subject><issn>0014-2999</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMtLAzEYxHNQbK3-CUqOLTb6Jeumm2MpPgoFDz6u5ctj29R9kaRiT_7rLvg4_ZgZGJgh5ILDNQcub54B-C0TSqkxwKQXIFh2RIb_9oCcxrgDgFyJ_IQMOMxmHLJ8SL7a2m2Q4QZT--kbunybs-ia6JP_cHSBY3E1oWaLTeMqqqvWvLswpVh1W2Rub12s22pKu9AmZ1KkfY9vYqI69KS-2e3DgWKZXKBla7CiPpqtqz32GQ2Y4hk5LrGK7vyXI_J6f_eyeGSrp4flYr5iHRciMV2UsrRSGOBWauWktrJQJRaKSylyxIIXwmgNtvdzXrh-X6at0NpaBeiyEbn86e32unZ23QVfYzis_57IvgHRqmEH</recordid><startdate>20000407</startdate><enddate>20000407</enddate><creator>Asakura, K</creator><creator>Matsuo, Y</creator><creator>Oshima, T</creator><creator>Kihara, T</creator><creator>Minagawa, K</creator><creator>Araki, Y</creator><creator>Kagawa, K</creator><creator>Kanemasa, T</creator><creator>Ninomiya, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20000407</creationdate><title>omega-agatoxin IVA-sensitive Ca(2+) channel blocker, alpha-eudesmol, protects against brain injury after focal ischemia in rats</title><author>Asakura, K ; Matsuo, Y ; Oshima, T ; Kihara, T ; Minagawa, K ; Araki, Y ; Kagawa, K ; Kanemasa, T ; Ninomiya, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p122t-b8f6fd62c01d6b9e6bd689fa8916625aa8182cbb0dd68518e7713bd2bbdd90ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Brain Edema - prevention &amp; control</topic><topic>Brain Ischemia - drug therapy</topic><topic>Calcium Channel Blockers - pharmacology</topic><topic>Cerebral Infarction - prevention &amp; control</topic><topic>Dose-Response Relationship, Drug</topic><topic>Glutamic Acid - metabolism</topic><topic>Male</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>omega-Agatoxin IVA - pharmacology</topic><topic>Potassium - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Rats, Wistar</topic><topic>Sesquiterpenes, Eudesmane</topic><topic>Terpenes - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Asakura, K</creatorcontrib><creatorcontrib>Matsuo, Y</creatorcontrib><creatorcontrib>Oshima, T</creatorcontrib><creatorcontrib>Kihara, T</creatorcontrib><creatorcontrib>Minagawa, K</creatorcontrib><creatorcontrib>Araki, Y</creatorcontrib><creatorcontrib>Kagawa, K</creatorcontrib><creatorcontrib>Kanemasa, T</creatorcontrib><creatorcontrib>Ninomiya, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Asakura, K</au><au>Matsuo, Y</au><au>Oshima, T</au><au>Kihara, T</au><au>Minagawa, K</au><au>Araki, Y</au><au>Kagawa, K</au><au>Kanemasa, T</au><au>Ninomiya, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>omega-agatoxin IVA-sensitive Ca(2+) channel blocker, alpha-eudesmol, protects against brain injury after focal ischemia in rats</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2000-04-07</date><risdate>2000</risdate><volume>394</volume><issue>1</issue><spage>57</spage><pages>57-</pages><issn>0014-2999</issn><abstract>omega-Agatoxin IVA-sensitive Ca(2+) channels have been thought to be involved in physiological excitatory amino acid glutamate release and these channels may also contribute to the development of ischemic brain injury. Recently, we demonstrated that alpha-eudesmol from Juniperus virginiana Linn. (Cupressaceae) inhibits potently the presynaptic omega-agatoxin IVA-sensitive Ca(2+) channels. In the present study, we investigated the effects of alpha-eudesmol on brain edema formation and infarct size determined after 24 h of reperfusion following 1 h of middle cerebral artery occlusion in rats. We first found that alpha-eudesmol concentration-dependently inhibited glutamate release from rat brain synaptosomes and that its inhibitory effect was Ca(2+)-dependent. In the middle cerebral artery occlusion study, intracerebroventricular (i.c.v.) treatment with alpha-eudesmol significantly attenuated the post-ischemic increase in brain water content. alpha-Eudesmol also significantly reduced the size of the infarct area determined by triphenyltetrazolium chloride staining after 24 h of reperfusion. Using a microdialysis technique, we further demonstrated that alpha-eudesmol inhibits the elevation of the extracellular concentration of glutamate during ischemia. From these results, we suggest that alpha-eudesmol displays an ability to inhibit exocytotic glutamate release and to attenuate post-ischemic brain injury.</abstract><cop>Netherlands</cop><pmid>10771035</pmid><doi>10.1016/S0014-2999(00)00102-3</doi></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 2000-04, Vol.394 (1), p.57
issn 0014-2999
language eng
recordid cdi_pubmed_primary_10771035
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Brain Edema - prevention & control
Brain Ischemia - drug therapy
Calcium Channel Blockers - pharmacology
Cerebral Infarction - prevention & control
Dose-Response Relationship, Drug
Glutamic Acid - metabolism
Male
Neuroprotective Agents - pharmacology
omega-Agatoxin IVA - pharmacology
Potassium - pharmacology
Rats
Rats, Sprague-Dawley
Rats, Wistar
Sesquiterpenes, Eudesmane
Terpenes - pharmacology
title omega-agatoxin IVA-sensitive Ca(2+) channel blocker, alpha-eudesmol, protects against brain injury after focal ischemia in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T14%3A15%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=omega-agatoxin%20IVA-sensitive%20Ca(2+)%20channel%20blocker,%20alpha-eudesmol,%20protects%20against%20brain%20injury%20after%20focal%20ischemia%20in%20rats&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Asakura,%20K&rft.date=2000-04-07&rft.volume=394&rft.issue=1&rft.spage=57&rft.pages=57-&rft.issn=0014-2999&rft_id=info:doi/10.1016/S0014-2999(00)00102-3&rft_dat=%3Cpubmed%3E10771035%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/10771035&rfr_iscdi=true